Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New share issue to raise funds for alpha-HGA development at Tripep

June 21, 2005

Vical receives HIV vaccine production order to support phase II trials

June 20, 2005

Expanded access program planned for protease inhibitor TMC-114

June 16, 2005

Trimeris, ChemBridge Research Laboratories to develop HIV entry inhibitors

June 16, 2005

Recent patents disclose novel treatments for HIV infection

June 15, 2005

Recent Bayer patent describes new antiretroviral agents

June 8, 2005

IR-103 to be studied in drug naive HIV patients

June 6, 2005

BioInvent set to begin U.K. study of BI-201 for HIV

June 3, 2005

Ranbaxy receives tentative approval for lamivudine tablets

June 1, 2005

CytoGenix licenses DNA plasmid from NIH

May 30, 2005

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...